As one of the most important non-communicable diseases of our time, diabetes affects both young and old, irrespective of gender or ethnicity. Beta-Cell’s cell replacement therapy brings a cure within reach for the first time. The mission of Beta-Cell is to provide a cure for type 1 insulin-dependent diabetes patients.
Diabetes is a chronic disorder characterized by elevated blood glucose levels. It arises when the natural interplay between the hormones insulin and glucagon fails. Current treatments manage and control blood glucose levels but do not cure the disease, putting a tremendous financial and mental burden on patients, families and society as a whole.
There is a significant unmet medical need for a safe, readily available and sustainable, physiologically regulated insulin source. BetaGraft cell factories mimic the biological action of the pancreas to restore cellular control of blood sugar levels with sustained adaptation to the needs of the body
Beta-Cell’s progress towards a cure for diabetes is driven by recognized scientific experts and an experienced leadership team. An actively engaged supervisory board supports this endeavor. Together we strive to create solutions that will have a profound impact on the everyday life of millions of patients.
You will also have the option to opt-out of these cookies should you want to. But opting out of some of these cookies may have effect on your browsing experience as per the descriptions elucidated against the respective categories below.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.